Our results also showed that the enhancement of tumor cell growth inhibition by melatonin is mediated through simultaneous modulation of caspase/cytochrome C, AP-2β/hTERT, NF-κB/COX-2, and Akt/ERK dependent signaling pathways. The gene discussed is TFAP2B; the disease is neoplasm.